Orphan designation: Heterologous swine glyco-humanised polyclonal antibody against T lymphocytes Treatment of peripheral T-cell lymphoma, 25/07/2024 Positive

Agenda - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (18 September 2024)

Orphan designation: Cannabidiol acid methyl ester Treatment of Prader-Willi syndrome, 25/07/2024 Positive

EMEA-003316-PIP01-22

Human medicines European public assessment report (EPAR): Adenuric, febuxostat, Date of authorisation: 21/04/2008, Revision: 23, Status: Authorised

EMEA-003346-PIP01-22

EMEA-003348-PIP01-22

EMEA-003415-PIP01-23

EMEA-003418-PIP01-23

EMEA-003423-PIP01-23